5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic and molecular characteristics of resected primary poorly differentiated thyroid carcinoma (PDTC): A single-institution retrospective study of 364 cases
    Meeting Abstract

    Xu, B.; Dogan, S.; Katabi, N.; Saliba, M.; Khimraj, A.; Fagin, J.; Ghossein, R.
    Laboratory Investigation (2021)

    Fulltext@MSK | Save
  • Neratinib-based combination therapy in her2-mutant lung adenocarcinomas: Findings from two international phase 2 studies
    Meeting Abstract

    Li, B.; Gandhi, L.; Besse, B.; Jhaveri, K.; MazieĢ€res, J.; Boni, V.; Shapiro, G.; Waqar, S.; Viteri, S.; Park, H.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of germline genetic testing criteria in early-onset kidney cancer
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Khurram, A.; Reisz, P.; Lenis, A. T.; Joseph, V.; Mandelker, D.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Single cell RNA sequencing of upper tract urothelial carcinoma to reveal significant heterogeneity of the tumor and immune microenvironment
    Meeting Abstract

    Reisz, P.; Tracey, A.; Kuo, F.; Thomas, J.; Clinton, T. N.; Lenis, A. T.; Truong, H.; Nagar, K.; Bochner, B. H.; Pietzak, E. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Rappold, P. M.; Silagy, A. W.; Kuo, F.; Marker, M.; Reising, A.; Millholland, J.; Russo, P.; Coleman, J.; Voss, M. H.; Chan, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Treatment results from a phase I study of WST11 phototherapy (VTP) for upper tract urothelial carcinoma
    Meeting Abstract

    Nogueira, L.; Tracey, A.; Alvim, R. G.; Reisz, P.; Sjoberg, D. D.; Demac, Q.; Benfante, N.; Nagar, K.; Thomas, J.; Cheng, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genomic characterization of bladder cancer with variant histology
    Meeting Abstract

    Lenis, A. T.; Clinton, T. N.; Hu, W.; Almassi, N.; Reisz, P.; Truong, H.; Thomas, J.; Nagar, K.; Goh, A.; Cha, E. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma
    Meeting Abstract

    Carlo, M. I.; Attalla, K.; Patil, S.; Murray, S. J.; Chen, Y. B.; Kotecha, R.; Durack, J. C.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B. M.; Ren, H.; Feliz, L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save